脑再生科技（RGC）今日盘中大涨28.59%，延续了近期脑机接口概念股的强势表现。
消息面上，特斯拉创始人马斯克近日在社交媒体宣布，其脑机接口公司Neuralink将于2026年开始大规模生产脑机接口设备，并实现高度自动化的手术方案。与此同时，中国工业和信息化部等八部门联合印发《“人工智能+制造”专项行动实施意见》，明确提出加快脑机接口等新型终端的产业化进程。这两大因素共同推动了脑机接口相关股票的上涨。
脑再生科技是一家专注于中医药治疗神经认知障碍和退化（如ADHD和自闭症谱系障碍）的生物科学公司，其业务方向与脑机接口技术高度相关。市场普遍认为，随着脑机接口技术的商业化加速，相关企业将迎来重大发展机遇。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.